Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_assertion type Assertion NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_head.
- NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_assertion description "[Gene transfer with VEGF-Adv or VEGF-P/L during PTCA and stenting shows that (1) intracoronary gene transfer can be performed safely (no major gene transfer-related adverse effects were detected), (2) no differences in clinical restenosis rate or minimal lumen diameter were present after the 6-month follow-up, and (3) a significant increase was detected in myocardial perfusion in the VEGF-Adv-treated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_provenance.
- NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_assertion evidence source_evidence_literature NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_provenance.
- NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_assertion SIO_000772 12742981 NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_provenance.
- NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_assertion wasDerivedFrom befree-20150227 NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_provenance.
- NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_assertion wasGeneratedBy ECO_0000203 NP771883.RAsRq-9mEkJBdbyAIFV_2SL4Fj_Vs8eYXq5Uy7udEMBnU130_provenance.